查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631478

鬱血性心臟衰竭設備市場規模、佔有率、趨勢分析報告：2025 年至 2030 年按產品、地區和細分市場分類的預測

Congestive Heart Failure Treatment Devices Market Size, Share & Trends Analysis Report By Product (Ventricular Assist Devices, Implantable Cardioverter Defibrillators, Counter Pulsation Devices, Pacemakers), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

鬱血性心臟衰竭市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球鬱血性心臟衰竭設備市場預計將在2030年達到82億美元，2025年至2030年期間的複合年成長率為6.7%。心血管疾病負擔的增加是推動該領域良好成長的關鍵因素之一。久坐的生活方式、精神壓力和食用垃圾食物的傾向是導致心血管疾病的主要因素。

美國醫療保險體係等優惠的報銷政策預計將成為該行業的主要成長要素。每家公司現在都提供具有報銷選項的新產品平台，使患者受益。報銷適用於心室輔助人工心臟裝置 (VAD)、植入式心臟整流去顫器(ICD) 和用於治療 CHF 的心律調節器等設備。

行業相關人員專注於開發能夠提供個人化護理的高度實用的產品。這些進步提供了額外的功能，可以提高準確性，增強工作流程並減少錯誤發生率。

鬱血性心臟衰竭設備市場報告重點

  • 依產品分類的市場分為輔助人工心臟輔助裝置、反搏裝置、ICD、心律調節器和心臟再同步裝置。 ICD 部分包括靜脈內和皮下兩種類型，將在 2024 年佔據有利佔有率，其次是心律調節器部分。這是因為心臟去顫器和心律調節器是治療心臟衰竭的第一線藥物。
  • 另一方面，由於保險報銷範圍的增加和心室輔助人工心臟的技術進步，輔助人工心臟（VAD）部分預計在預測期內將顯著成長。
  • 輔助人工心臟依植入部位不同，分為左心室輔助人工心臟（LVAD）及右心室輔助人工心臟（RVAD）。當 LVAD 和 RVAD 一起植入時，它們被稱為雙心室輔助裝置 (BIVAD)。
  • 2024 年北美鬱血性心臟衰竭設備市場佔據全球市場主導地位，佔有 45.6% 的佔有率。這是由於心血管疾病患病人口基數大，且老年人基數較大。
  • 市場參與企業正在積極致力於改善其當前的產品系列，以保持其在市場中的地位。此外，市場開發和對尚未開發國家的市場滲透預計將推動市場成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章鬱血性心臟衰竭設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 鬱血性心臟衰竭設備市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析

第 4 章鬱血性心臟衰竭市場：按產品分類的估計和趨勢分析

  • 全球鬱血性心臟衰竭設備市場：產品儀表板
  • 全球鬱血性心臟衰竭設備市場：產品差異分析
  • 全球鬱血性心臟衰竭治療設備市場（按產品和收益）
  • 輔助人工心臟(VAD)
    • LVAD
    • RVAD
    • 維瓦多
  • 反搏裝置
  • 植入式心臟整流去顫器
    • 靜脈 ICD
    • 皮下植入式心臟復律去顫器
  • 心律調節器
    • 嵌入式
    • 外部類型
  • 心臟再同步化治療
    • 心臟再同步治療心臟去顫器(CRT-D)
    • 心臟再同步治療心律心律調節器(CRT-P)

第 5 章鬱血性心臟衰竭市場：按地區分類的估計和趨勢分析

  • 區域控制面板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭格局

  • 公司/競爭對手分類
  • 供應商概況
    • 2024 年主要企業的市場佔有率分析
    • Jarvik Heart Inc.
    • ReliantHeart, Inc.
    • BIoTronik SE &Co. KG
    • Berlin Heart GmbH
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Teleflex, Inc.
Product Code: GVR-1-68038-292-1

Congestive Heart Failure Treatment Devices Market Growth & Trends:

The global congestive heart failure treatment devices market size is expected to reach USD 8.2 billion in 2030 and is projected to grow at a CAGR of 6.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.

Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.

The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.

Congestive Heart Failure Treatment Devices Market Report Highlights:

  • The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2024, which was followed by the pacemaker's segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
  • On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
  • The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
  • North America congestive heart failure treatment devices market dominated the global market with a 45.6% share in 2024, this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
  • The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Congestive Heart Failure Treatment Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cardiovascular diseases
      • 3.2.1.2. Technological advancements in heart failure treatment
      • 3.2.1.3. Growing awareness and early detection of heart failure
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of devices
      • 3.2.2.2. Complications and risks associated with device implantation
  • 3.3. Congestive Heart Failure Treatment Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Congestive Heart Failure Treatment Devices Market: Product Estimates & Trend Analysis

  • 4.1. Global Congestive Heart Failure Treatment Devices Market: Product Dashboard
  • 4.2. Global Congestive Heart Failure Treatment Devices Market: Product Movement Analysis
  • 4.3. Global Congestive Heart Failure Treatment Devices Market by Product, Revenue
  • 4.4. Ventricular Assist Devices
    • 4.4.1. Ventricular assist devices market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. LVAD
      • 4.4.2.1. LVAD market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. RVAD
      • 4.4.3.1. RVAD market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. BiVAD
      • 4.4.4.1. BiVAD market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Counter Pulsation Devices
    • 4.5.1. Counter pulsation devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Implantable Cardioverter Defibrillators
    • 4.6.1. Implantable cardioverter defibrillators market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Transvenous ICDs
      • 4.6.2.1. Transvenous ICDs market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Subcutaneous ICDs
      • 4.6.3.1. Subcutaneous ICDs market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Pacemakers
    • 4.7.1. Pacemakers market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.2. Implantable
      • 4.7.2.1. Implantable market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.7.3. External
      • 4.7.3.1. External market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Cardiac Resynchronization Therapy
    • 4.8.1. Cardiac resynchronization therapy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.2. Cardiac resynchronization therapy-defibrillators (CRT-D)
      • 4.8.2.1. Cardiac resynchronization therapy-defibrillators (CRT-D) market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.3. Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
      • 4.8.3.1. Cardiac Resynchronization Therapy-Pacemakers (CRT-P) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Congestive Heart Failure Treatment Devices Market: Regional Estimates & Trend Analysis by Product

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. Key company market share analysis, 2024
    • 6.2.2. Jarvik Heart Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. ReliantHeart, Inc.
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Biotronik SE & Co. KG
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Berlin Heart GmbH
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Abbott
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Medtronic
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Boston Scientific Corporation
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Teleflex, Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Mexico congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 Germany congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 UK congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 France congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Italy congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Spain congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Denmark congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Sweden congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Norway congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 China congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 Japan congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 India congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 South Korea congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 Australia congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Thailand congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Latin America congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Brazil congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 MEA congestive heart failure treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 31 South Africa congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait congestive heart failure treatment devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Congestive heart failure treatment devices market: market outlook
  • Fig. 7 Congestive heart failure treatment devices competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Congestive heart failure treatment devices market driver impact
  • Fig. 11 Congestive heart failure treatment devices market restraint impact
  • Fig. 12 Congestive heart failure treatment devices market: Product movement analysis
  • Fig. 13 Congestive heart failure treatment devices market: Product outlook and key takeaways
  • Fig. 14 Ventricular assist devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 LVAD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 RVAD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 BiVAD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Counter pulsation devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Implantable cardioverter defibrillators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Transvenous ICDs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Subcutaneous ICDs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Pacemakers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Implantable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 External market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Cardiac resynchronization therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Cardiac resynchronization therapy-defibrillators (CRT-D) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Cardiac resynchronization therapy-pacemakers (CRT-P) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global congestive heart failure treatment devices market: Regional movement analysis
  • Fig. 29 Global congestive heart failure treatment devices market: Regional outlook and key takeaways
  • Fig. 30 Global congestive heart failure treatment devices market share and leading players
  • Fig. 31 North America, by country
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. key country dynamics
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada key country dynamics
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico key country dynamics
  • Fig. 38 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 UK key country dynamics
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Germany key country dynamics
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France key country dynamics
  • Fig. 45 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China key country dynamics
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Japan key country dynamics
  • Fig. 60 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 India key country dynamics
  • Fig. 62 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand key country dynamics
  • Fig. 64 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea key country dynamics
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Australia key country dynamics
  • Fig. 68 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil key country dynamics
  • Fig. 71 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina key country dynamics
  • Fig. 73 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa key country dynamics
  • Fig. 76 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia key country dynamics
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 UAE key country dynamics
  • Fig. 80 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait key country dynamics
  • Fig. 82 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Market share of key market players- Congestive heart failure treatment devices market